Consistently elevated levels of oxidative markers like malondialdehyde (MDA), along with reduced activity of antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase, further underscore the role of redox imbalance in IBD progression [10,11]. This evidence concerns the gene SOD1 and inflammatory bowel disease.